{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-26-031792","form_type":"8-K","ticker":"OLMA","cik":"0001750284","company_name":"Olema Pharmaceuticals, Inc.","filed_at":"2026-01-30T23:59:59+00:00","discovered_at":"2026-05-14T18:02:36.071749+00:00","generated_at":"2026-05-16T06:00:57.417937+00:00","sec_items":["5.02","9.01"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.55,"calibrated_materiality_score":0.55,"confidence":"high","headline":"Olema CFO/COO Kovacs departs Jan 30; CEO Bohen interim principal financial officer","bullets":["Shane Kovacs, COO and CFO, leaves Jan 30, 2026; not due to disagreement with company on financial operations.","Kovacs receives $621,283 lump sum: $562,640 salary, $23,443 prorated 2026 bonus, $35,200 COBRA.","Outstanding equity awards continue vesting while he consults through Aug 1, 2026.","CEO Sean Bohen, M.D., Ph.D., assumes interim principal financial officer role; search for permanent CFO launched."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-26-031792","json":"https://secwatch.observer/filing/0001193125-26-031792.json","markdown":"https://secwatch.observer/filing/0001193125-26-031792.md","text":"https://secwatch.observer/filing/0001193125-26-031792.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1750284/000119312526031792/0001193125-26-031792-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1750284/000119312526031792/d126625d8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-16T06:00:57.417937+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}